Characterizing the glycosylation state of therapeutic recombinant glycoproteins

Methods in Molecular Biology

Volumn 951, Issue , 2013, Pages 323-334

  Samuels, Nicole ^a   Kates, David ^a   Liu, Jun ^a   Severs, Joanne ^a  

^a BAYER CORPORATION   (United States)

Author keywords

FVIII; Glycoprotein; Mass spectrometry; Recombinant

Indexed keywords

GLYCAN; GLYCOPROTEIN; RECOMBINANT BLOOD CLOTTING FACTOR 8; RECOMBINANT GLYCOPROTEIN; UNCLASSIFIED DRUG; BLOOD CLOTTING FACTOR 8; OLIGOSACCHARIDE; RECOMBINANT PROTEIN; THROMBIN;

ARTICLE; DRUG DETERMINATION; DRUG MANUFACTURE; DRUG SYNTHESIS; HEMOPHILIA; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; QUALITY CONTROL; CHEMISTRY; GLYCOSYLATION; HEMOPHILIA A; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLISM; PROTEIN DEGRADATION;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FACTOR VIII; GLYCOPROTEINS; GLYCOSYLATION; HEMOPHILIA A; HUMANS; MASS SPECTROMETRY; OLIGOSACCHARIDES; PROTEOLYSIS; RECOMBINANT PROTEINS; THROMBIN;

MLCS; MLOWN;

EID: 84878660589     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-146-2_22     Document Type: Article

References (12)

1. Hossler P, Khattak SF, Li ZJ (2009) Optimal and consistent protein glycosylation in mammalian cell culture. Glycobiology 19:936-949
2. Raju TS (2003) Glycosylation variations with expression systems and their impact on biological activity of therapeutic immunoglobulins. Bioprocess Int 1:44-53
3. Davies J, Jiang L, Pan LZ, LaBarre MJ, Anderson D, Reff M (2001) Expression of GnTIII in a recombinant anti-CD20 CHO production cell line: expression of antibodies with altered glycoforms leads to an increase in ADCC through higher affinity for FC gamma RIII. Biotechnol Bioeng 74:288-294
4. Bork K, Horstkorte R, Weidemann W (2009) Increasing the sialylation of therapeutic glycoproteins: the potential of the sialic acid biosynthetic pathway J. Pharm Sci.98:3499-3508
5. Bovenschen N, Rijken DC, Havekes LM, Van Vlijmen BJ, Mertens M (2005) The B domain of coagulation factor VIII interacts with the asialoglycoprotein receptor. J Thromb Haemost 3:1257-1265
6. Solá R, Griebenow K (2010) Glycosylation of therapeutic proteins. An effective strategy to optimize efficacy. BioDrugs 24:9-21
7. Purcell RT, Lockey RF (2008) Immunologic responses to therapeutic biologic agents. J Investig Allergol Clin Immunol 18:335-343
8. Chung CH, Mirakhur B, Chan E, Le QT, Berlin J, Morse M, Murphy BA, Satinover SM, Hosen J, Mauro D, Slebos RJ, Zhou Q, Gold D, Hatley T, Hicklin DJ, Platts-Mills TA (2008) Cetuximab-induced anaphylaxis and IgE specific for galactose-alpha-1, 3-galactose. N Engl J Med 358:1109-1117
9. Higgins E (2010) Carbohydrate analysis throughout the development of a protein therapeutic. Glycoconj J 27:211-225
10. Fang H, Wang L, Wang H (2007) The protein structure and effect offactor VIII. Thromb Res 119:1-13
11. White G, Pickens E, Liles D, Roberts H (1998) Mammalian recombinant coagulation proteins: structure and function. Transfus Sci 19:177-189
12. Anumula KR, Dhume ST (1998) High resolution and high sensitivity methods for oligosaccharide mapping and characterization by normal phase high performance liquid chromatography following derivatization with highly fluorescent anthranilic acid. Glycobiology 8:685-694